Literature DB >> 20190142

Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1.

Louise A Swainson1, Jeff E Mold, Urmila D Bajpai, Joseph M McCune.   

Abstract

CD4(+)FoxP3(+) regulatory T cells (T(reg)) play a critical role in maintaining self-tolerance and inhibiting autoimmune disease. Despite being a major focus of modern immunological investigation, many aspects of T(reg) biology remain unknown. In a screen for novel candidate genes involved in human T(reg) function, we detected the expression of an autoimmune susceptibility gene, FcRL3, in T(reg) but not in conventional CD4(+) T cells. FcRL3 is an orphan receptor of unknown function with structural homology to classical Fc receptors. Numerous genetic studies have demonstrated a link between a single nucleotide polymorphism in the FCRL3 promoter and both overexpression of FcRL3 and autoimmune diseases such as rheumatoid arthritis. Given the critical role of T(reg) in suppressing autoimmunity, we sought to ascertain how expression of FcRL3 relates to the phenotype, differentiation, and function of T(reg). We show in this study that FcRL3 is expressed on a population of thymically derived T(reg) that exhibits a memory phenotype and high levels of programmed cell death-1. Purified FcRL3(+) T(reg) are less responsive to antigenic stimulation in the presence of IL-2 than their FcRL3(-) counterparts, despite intact proximal and distal IL-2 signaling as determined by phosphorylation of Stat-5 and upregulation of Bcl2. In vitro suppression assays demonstrated that FcRL3(+) T(reg) have reduced capacity to suppress the proliferation of effector T cells. These data suggest that FcRL3 expression is associated with T(reg) dysfunction that may, in turn, contribute to the loss of self-tolerance and the development of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20190142      PMCID: PMC2894810          DOI: 10.4049/jimmunol.0903943

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.

Authors:  Steven J Bensinger; Patrick T Walsh; Jidong Zhang; Martin Carroll; Ramon Parsons; Jeffrey C Rathmell; Craig B Thompson; Matthew A Burchill; Michael A Farrar; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

2.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

3.  The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.

Authors:  C L Bennett; J Christie; F Ramsdell; M E Brunkow; P J Ferguson; L Whitesell; T E Kelly; F T Saulsbury; P F Chance; H D Ochs
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

4.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

5.  The inhibitory potential of Fc receptor homolog 4 on memory B cells.

Authors:  Gotz R A Ehrhardt; Randall S Davis; Joyce T Hsu; Chuen-Miin Leu; Annette Ehrhardt; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

6.  Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.

Authors:  Julia A Brown; David M Dorfman; Feng-Rong Ma; Elizabeth L Sullivan; Oliver Munoz; Clive R Wood; Edward A Greenfield; Gordon J Freeman
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

7.  SPAP2, an Ig family receptor containing both ITIMs and ITAMs.

Authors:  Ming-jiang Xu; Runxiang Zhao; Hongxi Cao; Zhizhuang Joe Zhao
Journal:  Biochem Biophys Res Commun       Date:  2002-05-10       Impact factor: 3.575

8.  Contrasuppression. A novel immunoregulatory activity.

Authors:  R K Gershon; D D Eardley; S Durum; D R Green; F W Shen; K Yamauchi; H Cantor; D B Murphy
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production.

Authors:  A M Thornton; E M Shevach
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  33 in total

Review 1.  Genetics of autoimmune diseases: perspectives from genome-wide association studies.

Authors:  Yuta Kochi
Journal:  Int Immunol       Date:  2016-02-08       Impact factor: 4.823

Review 2.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

3.  A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity.

Authors:  Urmila D Bajpai; Louise A Swainson; Jeff E Mold; Jonathan D Graf; John B Imboden; Joseph M McCune
Journal:  Arthritis Rheum       Date:  2012-08

Review 4.  Human regulatory T cells in autoimmune diseases.

Authors:  Gregory L Cvetanovich; David A Hafler
Journal:  Curr Opin Immunol       Date:  2010-09-24       Impact factor: 7.486

Review 5.  Treg cells in rheumatoid arthritis: an update.

Authors:  Faye A H Cooles; John D Isaacs; Amy E Anderson
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

6.  Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study.

Authors:  Menghui Yuan; Longxiao Wei; Runsuo Zhou; Qianrong Bai; Yixin Wei; Wei Zhang; Yong Huang
Journal:  Mol Neurobiol       Date:  2015-04-11       Impact factor: 5.590

Review 7.  CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.

Authors:  S Alice Long; Jane H Buckner
Journal:  J Immunol       Date:  2011-09-01       Impact factor: 5.422

8.  FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation.

Authors:  Fu Jun Li; Daniel M Schreeder; Ran Li; Jiongru Wu; Randall S Davis
Journal:  Eur J Immunol       Date:  2013-08-12       Impact factor: 5.532

9.  Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.

Authors:  Khalid Bin Dhuban; Eva d'Hennezel; Emil Nashi; Amit Bar-Or; Sadiye Rieder; Ethan M Shevach; Satoshi Nagata; Ciriaco A Piccirillo
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

10.  A towards-multidimensional screening approach to predict candidate genes of rheumatoid arthritis based on SNP, structural and functional annotations.

Authors:  Liangcai Zhang; Wan Li; Leilei Song; Lina Chen
Journal:  BMC Med Genomics       Date:  2010-08-20       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.